By Alexis Achong

In Nigeria, the burden of endocrine disorders, particularly diabetes and thyroid-related diseases, has been on the rise.

The World Health Organization (WHO) and the International Diabetes Federation (IDF) have consistently reported increasing cases of diabetes across Africa, with Nigeria being one of the most affected countries.

While endocrinologists play a critical role in managing these conditions, their limited numbers make it difficult to provide specialized care to the millions of patients in need.

Consequently, empowering general practitioners (GPs) and non-endocrinologists with the knowledge and tools to manage endocrine disorders has emerged as a transformative strategy in improving treatment outcomes and enhancing patient experience.

Bridging the Gap in Specialist Care

With Nigeria’s population exceeding 180 million in 2016, the ratio of endocrinologists to patients remained alarmingly low, leaving a significant portion of the population without access to specialized care.

Given this shortage, general practitioners and primary care physicians often serve as the first point of contact for individuals with diabetes and other endocrine disorders.

Strengthening their capacity to diagnose, treat, and manage these conditions effectively can help bridge the gap in healthcare delivery and reduce complications arising from delayed specialist intervention.

According to Olu James Mbanugo, District Manager, Sanofi, empowering non-endocrinologists is key to addressing this gap.

Through Sanofi’s medical education programs, GPs are being trained on early symptom recognition, laboratory result interpretation, and evidence-based treatment regimens before specialist referral becomes necessary.

“By equipping general practitioners with the right knowledge and tools, we are not only improving access to care but also enhancing the quality of treatment patients receive,” says Mbanugo.

One of such programs that Mbanugo is using to drive this initiative is the Diabetes Centres of Excellence, where he gathered over a hundred non-endocrinologists and GPs monthly across different locations to be trained by endocrinologists.

Improving Treatment Outcomes through Early Intervention

One of the critical benefits of empowering non-endocrinologists is the ability to detect endocrine disorders at earlier stages, reducing the incidence of complications such as diabetic neuropathy, nephropathy, and cardiovascular diseases.

When trained properly, general practitioners can initiate early interventions such as lifestyle modifications, medication adjustments, and patient counseling, significantly improving long-term health outcomes.

Moreover, advancements in telemedicine and digital health platforms have made it easier for GPs to consult with specialists remotely.

Mbanugo highlights that Sanofi’s training programs leverage digital tools, enabling doctors in rural and underserved areas to access expert guidance, improving decision-making and patient care.

With the right tools and continuous support, GPs can manage stable diabetic patients efficiently, freeing up endocrinologists to focus on more complex cases.

Enhancing the Patient Experience

For many Nigerians, navigating the healthcare system can be a frustrating experience due to long wait times, limited specialists, and high consultation costs.

By empowering general practitioners with specialized training, patients can receive quality care closer to home, reducing unnecessary referrals and travel expenses.

This approach not only improves accessibility but also fosters better doctor-patient relationships, as GPs become more involved in long-term patient management.

Additionally, educating general practitioners on patient-centered care has led to improved adherence to treatment plans.

When patients receive consistent follow-ups and clear explanations about their condition, they are more likely to comply with prescribed medications and lifestyle changes.

This has been particularly beneficial in diabetes management, where long-term adherence to treatment significantly reduces complications and hospitalizations.

A Collaborative Future in Endocrine Care

As Nigeria continues to face the growing challenge of non-communicable diseases, it is crucial for stakeholders—including the government, medical institutions, and pharmaceutical companies—to invest in the training and capacity-building of general practitioners.

Strengthening collaborations between specialists and GPs, expanding telemedicine initiatives, and integrating digital health solutions into routine clinical practice will further enhance the quality of care for patients with endocrine disorders.

Mbanugo emphasizes that empowering non-endocrinologists is not about replacing specialists but rather ensuring that every patient, regardless of location or socioeconomic status, receives timely and effective treatment.

He calls on health policymakers, private healthcare providers, and international organizations to scale up investments in training programs and promote initiatives that integrate technology-driven diagnostic tools into primary care settings.

“With continued investment in medical education and collaborative healthcare strategies, Nigeria is well on its way to transforming treatment outcomes and patient experiences for millions living with endocrine disorders,” Mbanugo concludes.